President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.
Tom Murphy
Murphy covers how people and businesses navigate the U.S. health care system. He is a member of AP’s Health and Science team.
